Autolus Therapeutics plc - American Depositary Share (AUTL) Social Stream
AUTOLUS THERAPEUTICS PLC (AUTL) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering AUTOLUS THERAPEUTICS PLC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-04 | 6 | $21 | $7 | $13.2 | $4.28 | 208.41% |
| 2021-12-20 | 5 | $21 | $7 | $12.8 | $4.28 | 199.07% |
| 2022-03-31 | 6 | $21 | $7 | $12.8 | $4.28 | 199.07% |
| 2022-05-06 | 6 | $13 | $7 | $10.75 | $4.28 | 151.17% |
| 2022-05-16 | 5 | $13 | $7 | $10.75 | $4.28 | 151.17% |
| 2022-08-05 | 5 | $12 | $7 | $10.25 | $4.28 | 139.49% |
| 2022-08-18 | 6 | $12 | $7 | $10.6 | $4.28 | 147.66% |
| 2022-11-04 | 6 | $12 | $7 | $10.4 | $4.28 | 142.99% |
| 2022-12-09 | 6 | $12 | $7 | $9.4 | $4.28 | 119.63% |
| 2023-01-04 | 5 | $12 | $6 | $8.6 | $4.28 | 100.93% |
| 2023-03-08 | 7 | $12 | $6 | $8.833 | $4.28 | 106.38% |
| 2023-05-05 | 6 | $12 | $6 | $8.4 | $4.28 | 96.26% |
| 2023-08-04 | 7 | $12 | $5 | $7.833 | $4.28 | 83.01% |
| 2023-08-17 | 7 | $12 | $5 | $8.333 | $4.28 | 94.7% |
| 2023-11-02 | 6 | $12 | $6 | $9 | $4.28 | 110.28% |
| 2023-11-29 | 7 | $12 | $6 | $9.166 | $4.28 | 114.16% |
The Trend in the Analyst Price Target
Over the past 19 days, AUTL's average price target has gone down $0.
AUTL reports an average of 227.9% for its upside potential over the past 51 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-08 | 7 | 12 | 6 | 8.833 | 2.04 | 332.99% |
| 2023-04-05 | 6 | 12 | 6 | 8.400 | 1.82 | 361.54% |
| 2023-05-05 | 6 | 12 | 5 | 8.200 | 1.89 | 333.86% |
| 2023-11-10 | 7 | 12 | 6 | 9.166 | 3.43 | 167.23% |
| 2023-11-29 | 7 | 12 | 6 | 9.166 | 4.08 | 124.66% |
AUTL Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.14 | 6 | 1 | 0 | 0 | 0 | 7 |
The Trend in the Broker Recommendations
AUTL's average broker recommendation rating improved by 0.36 over the prior 15 months.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- To contextualize these metrics, consider that out of all US stocks, AUTOLUS THERAPEUTICS PLC's average analyst price target is higher than 207.93% of them.
- To contextualize these metrics, consider that out of all US stocks, AUTOLUS THERAPEUTICS PLC's upside potential (average analyst target price relative to current price) is higher than 1510.5% of them.
- To contextualize these metrics, consider that out of all US stocks, AUTOLUS THERAPEUTICS PLC's variance in analysts' estimates is lower than -1333.21% of them.
- In the context of stocks in the small market cap category, AUTOLUS THERAPEUTICS PLC's number of analysts covering the stock is greater than 1313.77% of them.
Stocks similar to AUTOLUS THERAPEUTICS PLC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are AVRO, MGTX, and SRRK.
View All Top Stocks by Price Target
What is the outlook for AUTL? Use POWR Ratings for clearer insight into price direction.